Question 1

How many shares of SVA does Skandinaviska Enskilda Banken AB (publ) own?

Accepted Answer

As of 2026-Q2, Skandinaviska Enskilda Banken AB (publ) holds 40,000 shares of SVA (SINOVAC BIOTECH LTD).

Question 2

What is Skandinaviska Enskilda Banken AB (publ)'s SVA position worth?

Accepted Answer

As of 2026-Q2, Skandinaviska Enskilda Banken AB (publ)'s SVA position is worth $0.

Question 3

Is Skandinaviska Enskilda Banken AB (publ) buying or selling SVA?

Accepted Answer

In 2026-Q2, Skandinaviska Enskilda Banken AB (publ) decreased their SVA position (-50.0% change in shares).

Question 4

When did Skandinaviska Enskilda Banken AB (publ) first buy SVA?

Accepted Answer

Based on available 13F filings, Skandinaviska Enskilda Banken AB (publ) first reported a position in SVA in 2024-Q3. They have held the position across 25 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	40,000	-50.0%	$0	0.0%	$6.47	0
2026-Q1	Increased	80,000	+100.0%	$0	0.0%	$6.47	12
2025-Q4	Unchanged	40,000	0.0%	$0	0.0%	$6.47	0
2025-Q3	Unchanged	40,000	0.0%	$0	0.0%	$6.47	0
2025-Q2	New	40,000	-	$0	0.0%	—	17
2024-Q3	Exited	0	-100.0%	$0	0.0%	—	0

SVAShowing 6 of 25 quarters

SVA
Showing 6 of 25 quarters